EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Resistant starch and type 2 diabetes mellitus: Clinical perspective

Min Kyung Kim iD, Juri Park iD, Doo-Man Kim iD

Journal of Diabetes Investigation · 2024-04 · 15 (4) · 395-401

DOI: 10.1111/jdi.14139 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Diabetes Investigation, online erschienen am 08.01.2024. Verfasst von Min Kyung Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Resistant Starch, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The immediate and well‐documented benefits of carbohydrate restriction include improved glycemic control in individuals with diabetes mellitus. Starch, a significant source of carbohydrates, is categorized as rapidly digestible, slowly digestible, or resistant starch (RS). RS, which is a non‐viscous fermentable fiber, has shown promise in animal studies for antidiabetic effects by improving glucose metabolism. Although the exact mechanism by which RS affects glucose metabolism remains unclear, it is expected to positively impact glucose tolerance and insulin sensitivity. The fermentation of RS by colonic microbiota in the large bowel produces short‐chain fatty acids, which exert multiple metabolic effects on glucose regulation and homeostasis. Moreover, RS may influence glucose metabolism via bile acid modulation, independent of its fermentation. Diets rich in RS could aid in blood glucose homeostasis. However, it is uncertain whether they can alter the metabolic pathology associated with glucose regulation. In essence, RS has the potential to lower postprandial glucose levels similarly to a low‐glycemic index diet. Yet, its efficacy as a medical nutrition therapy for type 2 diabetes needs further investigation. To confirm the role of RS in glycemic control and to possibly recommend it as an additional dietary approach for people with type 2 diabetes mellitus, a well‐designed, large‐scale intervention is required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Resistant StarchDiabetes Mellitus, Type 2AnimalsHumansInsulinStarchBlood GlucoseGlucoseDietary Carbohydrates

Stichwörter der Autor:innen

Diabetes mellitus, type 2DietResistant starch

Substanzen

Resistant StarchInsulinStarchBlood GlucoseGlucoseDietary Carbohydrates

Autor:innen und Institutionen

  • Department of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, South Korea.
  • Department of Internal Medicine, Shihwa Medical Center, Shihwa, South Korea.

ORCID-Profile: Min Kyung Kim, Juri Park, Doo-Man Kim

Zitieren

APA

Kim, M. K., Park, J., & Kim, D. M. (2024). Resistant starch and type 2 diabetes mellitus: Clinical perspective. Journal of Diabetes Investigation, 15(4), 395-401. https://doi.org/10.1111/jdi.14139

Vancouver

Kim MK, Park J, Kim DM. Resistant starch and type 2 diabetes mellitus: Clinical perspective. Journal of Diabetes Investigation. 2024;15(4):395-401. doi:10.1111/jdi.14139

BibTeX
@article{Kim2024,
  author = {Kim, Min Kyung and Park, Juri and Kim, Doo-Man},
  title = {Resistant starch and type 2 diabetes mellitus: Clinical perspective},
  journal = {Journal of Diabetes Investigation},
  year = {2024},
  volume = {15},
  number = {4},
  pages = {395--401},
  doi = {10.1111/jdi.14139}
}
Kostenlos starten →